Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.

Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ.

Biol Blood Marrow Transplant. 2003 Oct;9(10):657-66.

2.

Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning.

Paz HL, Crilley P, Topolsky DL, Coll WX, Patchefsky A, Brodsky I.

Respiration. 1993;60(2):109-14.

PMID:
8341852
3.
4.
5.

Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation.

Duncan CN, Buonanno MR, Barry EV, Myers K, Peritz D, Lehmann L.

Bone Marrow Transplant. 2008 Jun;41(11):971-5. doi: 10.1038/bmt.2008.19. Epub 2008 Feb 25.

PMID:
18297116
6.

Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D.

Blood. 1995 Nov 15;86(10):3979-86. Review.

7.

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM).

Socié G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N, Milpied N, Michallet M, Lioure B, Pico JL, Witz F, Molina L, Fischer A, Bardou VJ, Gluckman E, Reiffers J.

Br J Haematol. 1997 Jun;97(4):865-70.

PMID:
9217190
8.

Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center.

Griese M, Rampf U, Hofmann D, Führer M, Reinhardt D, Bender-Götze C.

Pediatr Pulmonol. 2000 Nov;30(5):393-401.

PMID:
11064430
9.

Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation.

Nakaseko C, Ozawa S, Sakaida E, Sakai M, Kanda Y, Oshima K, Kurokawa M, Takahashi S, Ooi J, Shimizu T, Yokota A, Yoshiba F, Fujimaki K, Kanamori H, Sakai R, Saitoh T, Sakura T, Maruta A, Sakamaki H, Okamoto S.

Int J Hematol. 2011 Mar;93(3):375-82. doi: 10.1007/s12185-011-0809-8. Epub 2011 Mar 19.

PMID:
21424350
10.

Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.

Ochs LA, Miller WJ, Filipovich AH, Haake RJ, McGlave PB, Blazar BR, Ramsay NK, Kersey JH, Weisdorf DJ.

Bone Marrow Transplant. 1994 Apr;13(4):455-60.

PMID:
8019471
11.

Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.

Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y; Japan Marrow Donor Program..

Br J Haematol. 2007 Apr;137(2):142-51.

PMID:
17391494
12.

Pulmonary function changes in long-term survivors of chronic myelogenous leukemia after allogeneic bone marrow transplantation: a Taiwan experience.

Chiou TJ, Tung SL, Wang WS, Tzeng WF, Yen CC, Fan FS, Liu JH, Chen PM.

Cancer Invest. 2002;20(7-8):880-8.

PMID:
12449718
13.

Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.

Nevo S, Enger C, Swan V, Wojno KJ, Fuller AK, Altomonte V, Braine HG, Noga SJ, Vogelsang GB.

Transplantation. 1999 Mar 15;67(5):681-9.

PMID:
10096522
14.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.

J Clin Oncol. 2004 Feb 1;22(3):416-23. Epub 2003 Dec 22.

PMID:
14691124
15.

Chronic graft-versus-host disease: a prospective cohort study.

Arora M, Burns LJ, Davies SM, Macmillan ML, Defor TE, Miller WJ, Weisdorf DJ.

Biol Blood Marrow Transplant. 2003 Jan;9(1):38-45.

16.

Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.

Yumura-Yagi K, Inoue M, Sakata N, Okamura T, Yasui M, Nakano T, Nomura K, Nakano T, Park DY, Endo C, Nishiuchi R, Sawada A, Matsuda Y, Oota H, Yoshimoto T, Kawa-Ha K.

Int J Hematol. 2000 Apr;71(3):278-82.

PMID:
10846836
17.

Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.

El-Sayed MH, El-Haddad A, Fahmy OA, Salama II, Mahmoud HK.

Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1347-54.

PMID:
15618844
18.
19.

Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.

Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A, van Lint M, Gratwohl A, Kolb HJ.

Bone Marrow Transplant. 1996 Jun;17(6):1105-11.

PMID:
8807122
20.

Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.

Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera GB, Bacigalupo A.

Haematologica. 2003 Oct;88(10):1163-8.

Supplemental Content

Support Center